Logo

gastrointestinal disease

Takeda Crohn's Disease Risk Assay Aims to Help Patients Better Manage Ailment
Premium

The CDPath prognostic tool gives Crohn's patients risk scores for serious complications within three years, so they can make more informed treatment decisions.

Eagle Biosciences, Genetic Analysis Ink Distribution Agreement for Gut Microbiota Test

Under the agreement, Eagle Biosciences will distribute Genetic Analysis' GA-map Dysbiosis fecal gut microbiota test in North America.

DiaSorin to Acquire Luminex for $1.8B

DiaSorin said that the transaction is expected to be immediately accretive to its earnings per share and result in cost synergies of about $55 million within three years.

DARPA Programs Leveraging Host-Response Testing, CRISPR for Future Pandemic Preparedness
Premium

DARPA program managers said they are developing different testing modalities that are crucially linked in their objective to facilitate more comprehensive and faster testing.

Appendiceal Cancer Sequences Suggest Distinct Mutation Patterns in Early-, Late-Onset Cases

With clinical sequencing data for almost 400 appendiceal cancer cases, researchers identified somatic differences in individuals diagnosed with the disease before the age of 50.

Jul 8, 2020

Twist Bioscience, Takeda Pharma Partner to Develop Antibodies for Oncology, Rare Diseases

Jan 9, 2020

Australian Firm Genetic Signatures to Enter US Market With Syndromic Kit for GI Conditions
Premium

Jan 8, 2020

Applied BioCode Receives FDA Clearance for Syndromic Respiratory Pathogen Panel

Oct 9, 2019

Japanese Informatics Firm Genomedia Sees SCRUM Cancer Project as Path to Wider Adoption
Premium

Oct 9, 2019

Mobidiag Gets CE Mark for Intestinal Parasites Test

Oct 8, 2019

Serosep, Quidel Ink US Distribution Deal for GI Panel

Sep 4, 2019

uBiome Declares Bankruptcy, Offers Assets for Sale

Jun 12, 2019

FDA Clears Roche Extraction Platform For Use With Applied BioCode GI Pathogen Panel, System

Apr 11, 2019

Hirschsprung's Disease Genetic Analysis Reveals Mix of Common, Rare Risk Variants

Nov 30, 2018

Gallstone Disease Meta-Analysis Leads to Bile Transport, Cholesterol Pathways

Oct 11, 2018

Undiagnosed Diseases Network Reports Diagnostic Rates, Impact on Treatment

Oct 2, 2018

Ariel Precision Medicine Launches Clinical Decision Support for NGS Pancreatitis Assay
Premium

Sep 4, 2018

Diverticular Disease GWAS Leads to Dozens of New Risk Loci

Aug 2, 2018

Becton Dickinson Reports 41 Percent Increase in Fiscal Q3 Revenues

Feb 5, 2018

Qiagen to Enter Multiplex Infectious Disease Testing Market With Stat-Dx Buy
Premium

Jan 4, 2018

Applied BioCode Submits MDx Platform, GI Panel for 510(k) Clearance

Nov 27, 2017

Interlux to Distribute Mobidiag Products in Estonia

Nov 7, 2017

Progenity Closes $125M Series B Financing Round

Jun 29, 2017

Rare Gut Condition Linked to Single Gene Mutations, Hyperactivation of Complement System

Apr 20, 2017

Applied Biocode to Submit Gastrointestinal Pathogen Panel to FDA in Bid to Displace Luminex
Premium

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.